Yan Fei Lu

US Patent:

20050123912, Jun 9, 2005

Filed:

Aug 14, 2002

Appl. No.:

10/486977

Inventors:

Ines Barroso - Cambridge, GB
Mariah Baughn - Los Angeles CA, US
Shanya Becha - San Francisco CA, US
Julie Blake - San Francisco CA, US
Mark Borowsky - Needham MA, US
Neil Burford - Durham CT, US
Brendan Duggan - Sunnyvale CA, US
Vicki Elliott - San Jose CA, US
Brooke Emerling - Chicago IL, US
Ian Forsythe - Edmonton, CA
Kimberly Gietzen - San Jose CA, US
Ann Gorvad - Bellingham WA, US
Jennifer Griffin - Fremont CA, US
April Hafalia - Daly City CA, US
Cynthia Honchell - San Francisco CA, US
Craig Ison - San Jose CA, US
Farrah Khan - Canton MI, US
Preeti Lal - Santa Clara CA, US
Ernestine Lee - Kensington CA, US
Sally Lee - San Jose CA, US
Soo Lee - Mountain View CA, US
Joana Li - Millbrae CA, US
Dyung Lu - San Jose CA, US
Yan Lu - Mountain View CA, US
Danniel Nguyen - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
William Sprague - Sacramento CA, US
Y Tang - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Michael Thornton - Oakland CA, US
Uyen Tran - San Jose CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - San Marcos CA, US
Yuming Xu - Mountain View CA, US
Monique Yao - Mountain View CA, US
Henry Yue - Sunnyvale CA, US
Huibin Yue - Cupertino CA, US
Yeganeh Zebarjadian - San Francisco CA, US

International Classification:

C12Q001/68
C07H021/04
C12N009/22

US Classification:

435006000, 435069100, 435199000, 435320100, 435325000, 536023200

Abstract:

Various embodiments of the invention provide human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.

US Patent:

20060194275, Aug 31, 2006

Filed:

Apr 12, 2002

Appl. No.:

10/474894

Inventors:

Mariah Baughn - LOS ANGELES CA, US
Vicki Elliott - San Jose CA, US
April Hafalia - Daly City CA, US
Junming Yang - San Jose CA, US
Narinder Chawla - Union City CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Ian Forsythe - Edmonton CA, US
Yan Lu - Mountain View CA, US
Y Tom Tang - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Brigitte Raumann - Chicago IL, US
Preeti Lal - Santa Clara CA, US
Yalda Azimzai - Oakland CA, US
Dyung Lu - San Jose CA, US
Ameena Gandhi - San Frnacisco CA, US
Michael Thornton - Oakland CA, US
Danniel Nguyen - San Jose CA, US
Chandra Arvizu - San Diego CA, US
Brooke Emerling - Chicago IL, US
Anita Swarnakar - San Francisco CA, US
Monique Yao - Mountain View CA, US
Li Ding - Creve Coeur MO, US
Ann He - San Jose CA, US
Jennifer Griffin - Fremont CA, US
Madhusudan Sanjanwala - Los Altos CA, US
Kimberly Gietzen - San Jose CA, US
Ernestine Lee - Kensington CA, US
Yuming Xu - Mountain View CA, US
Janice Au-Young - Brisbane CA, US
Debopriya Das - Oyster Bay NY, US
Soo Lee - Mountain View CA, US
Hsin-Ru Chang - Belmont CA, US

Assignee:

INCYTE CORPORATION - PALO ALTO CA

International Classification:

C07K 14/705
C07H 21/04
C12P 21/06

US Classification:

435069100, 435320100, 435325000, 530350000, 536023500

Abstract:

The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.